The prevalence and treatment patterns of familial hypercholesterolemia among Thai patients with premature coronary artery disease

References

• Austin MA, et al. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol. 2004;160(5):407–420.
   PubMed Web of Science ®Google Scholar
• Henderson R, O’Kane M, McGilligan V, et al. The genetics and screening of familial hypercholesterolaemia. J Biomed Sci. 2016;23:39.
   PubMed Web of Science ®Google Scholar
• Jl G, Hh H, MS B. The metabolic and molecular bases of inherited disease. In: Scriver CR, Beaudet AL, Sly WS, et al., editors. Familial hypercholesterolemia. 8th ed. New York: McGraw-Hill Information Services Company; 2001. p. 2863–2913.
   Google Scholar
• Bertolini S, Pisciotta L, Rabacchi C, et al. Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy. Atherosclerosis. 2013;227:342–348
   PubMed Web of Science ®Google Scholar
• Moorjani S, Roy M, Torres A, et al. Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia. Lancet. 1993;341:1303–1306.
   PubMed Web of Science ®Google Scholar
• LE A, Genest J, SD S, et al. Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. BMJ Open. 2017;7(9):e016461.
   PubMed Web of Science ®Google Scholar
• SO B, Cm M, Varbo A, et al. Worldwide Prevalence of Familial Hypercholesterolemia: meta-Analyses of 11 Million Subjects. J Am Coll Cardiol. 2020;75(20):2553–2566.
   PubMed Web of Science ®Google Scholar
• Representatives of the Global Familial Hypercholesterolemia Community, KA W, Patel J, Aguilar-Salinas C, et al. Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action. JAMA Cardiol. 2020;5(2):217–229.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Familial hypercholesterolemia—report of a second WHO Consultation. Geneva Switzerland: World Health Organization; 1999.
   Google Scholar
• Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ. 1991;303(6807):893–896.
   PubMedGoogle Scholar
• Williams RR, Hunt SC, Schumacher MC, et al. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol. 1993;72(2):171–176.
   PubMed Web of Science ®Google Scholar
• Pongrapeeporn KU, Sutthikhum V, Likidlilid A, et al. Screening for mutations in exon 4 of the LDL receptor gene in Thai subjects with primary hypercholesterolemia: detection of a novel mutation D151Y by PCR-CFLP. J Med Assoc Thai. 2000;83 Suppl 2:S66–73.
   PubMedGoogle Scholar
• Pongrapeeporn K-US, Nuinoon M, Thepsuriyanont P, et al. Detection of a known mutation M412T in the LDL receptor in a Chinese Thai FH family. Clin Chim Acta. 2006;365(1–2):211–216.
   PubMed Web of Science ®Google Scholar
• Jeenduang N, Ruangpracha A, Promptmas C, et al. Two novel D151Y and M391T LDLR mutations causing LDLR transport defects in Thai patients with familial hypercholesterolemia. Clin Chim Acta. 2010;411(21–22):1656–1661.
   PubMed Web of Science ®Google Scholar
• Nanchen D, Gencer B, Auer R, et al. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes. Eur Heart J. 2015;36:2438–2445.
   PubMed Web of Science ®Google Scholar
• SA R, LE B, UM M, et al. The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction. Am Heart J. 2016;181:35–42.
   PubMed Web of Science ®Google Scholar
• Tscharre M, Herman R, Rolha M, et al. Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention. J Clin Lipidol. 2019;13:115–122.
   PubMed Web of Science ®Google Scholar
• The Royal College of Physicians of Thailand. 2016 RCPT clinical practice guideline on pharmacologic therapy of dyslipidemia for atherosclerotic cardiovascular disease prevention. 2016. http://www.thaiheart.org/download/2016-RCPT-Dyslipidemia-Guideline.html. Accessed 2022 Sep 5.
   Google Scholar
• Yudi M, Omera L, McCubbery N, et al. Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease. Singapore Med J. 2012;53(3):174–178.
   PubMed Web of Science ®Google Scholar
• Lorca R, Aparicio A, Cuesta-Llavona E, et al. Familial hypercholesterolemia in premature acute coronary syndrome. Insights from cholestemi registry. J Clin Med. 2020;9(11):3489.
   PubMed Web of Science ®Google Scholar
• DS W, FA B, Bestwick JP. Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction. Eur J Intern Med. 2015;26:127–130.
   PubMed Web of Science ®Google Scholar
• MP B, Lkl Ø, Halvorsen S, et al. Prevalence of genetically verified familial hypercholesterolemia among young (<45 years) Norwegian patients hospitalized with acute myocardial infarction. J Clin Lipidol. 2020;14(3):339–345.
   PubMed Web of Science ®Google Scholar
• LS R, AS T, Tsirebolos G, et al. Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins. Atherosclerosis. 2016;249:17–21.
   PubMed Web of Science ®Google Scholar
• AI K, Trinder M, Brunham LR. Estimating the prevalence of familial hypercholesterolemia in acute coronary syndrome: a systematic review and meta-analysis. Can J Cardiol. 2019;35(10):1322–1331.
   PubMed Web of Science ®Google Scholar
• Hu P, KI D, CAT S, et al. Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis. Circulation. 2020;141(22):1742–1759.
   PubMed Web of Science ®Google Scholar
• Hw S, JG Y, Wang Y, et al. The prevalence of familial hypercholesterolemia (FH) in Chinese patients with acute myocardial infarction (AMI): data from Chinese acute myocardial infarction (CAMI) registry. Front Cardiovasc Med. 2020;7:113.
   PubMed Web of Science ®Google Scholar
• Toell T, Mayer L, Pechlaner R, et al. Familial hypercholesterolaemia in patients with ischaemic stroke or transient ischaemic attack. Eur J Neurol. 2018;25:260–267.
   PubMed Web of Science ®Google Scholar
• Yasuda T, Shimizu M, Ino H, et al. Coronary lesion morphology and prognosis in young males with myocardial infarction with or without familial hypercholesterolemia. Jpn Circ J. 2001;65(4):247–250.
   PubMedGoogle Scholar
• Béliard S, Millier A, Carreau V, et al. French FH Registry group. The very high cardiovascular risk in heterozygous familial hypercholesterolemia: analysis of 734 French patients. J Clin Lipidol. 2016;10(5):1129–1136.
   PubMed Web of Science ®Google Scholar
• Giral P, Bruckert E, Dairou F, et al. Usefulness in predicting coronary artery disease by ultrasonic evaluation of the carotid arteries in asymptomatic hypercholesterolemic patients with positive exercise stress tests. Am J Cardiol. 1999;84(1):14–17.
   PubMed Web of Science ®Google Scholar
• Farnier M, Salignon-Vernay C, Yao H, et al. Prevalence, risk factor burden, and severity of coronary artery disease in patients with heterozygous familial hypercholesterolemia hospitalized for an acute myocardial infarction: data from the French RICO survey. J Clin Lipidol. 2019;13(4):601–607.
   PubMed Web of Science ®Google Scholar
• Harada-Shiba M, Ako J, Arai H, et al. Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: results of the EXPLORE-J study. Atherosclerosis. 2018;277:362–368.
   PubMed Web of Science ®Google Scholar
• Al-Rasadi K, Al-Zakwani I, Aa A-A, et al. Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf. J Clin Lipidol. 2018;12(3):685–692.
   PubMed Web of Science ®Google Scholar
• Perez de Isla L, Alonso R, Gf W, et al. SAFEHEART Investigators. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up. J Am Coll Cardiol. 2016;67(11):1278–1285.
   PubMed Web of Science ®Google Scholar
• Faggiano P, Pirillo A, Griffo R, et al. Centro Studie Formazione - Italian Association for Cardiovascular Prevention and Rehabilitation. Prevalence and management of familial hypercholesterolemia in patients with coronary artery disease: the heredity survey. Int J Cardiol. 2018;252:193–198.
   PubMed Web of Science ®Google Scholar
• Mülverstedt S, PR H, Prescott E, et al. Screening for potential familial hypercholesterolaemia in general practice: an observational study on prevalence and management. BJGP Open. 2021;5(2):20X101142.
   Google Scholar
• Genest J. Combination of statin and ezetimibe for the treatment of dyslipidemias and the prevention of coronary artery disease. Can J Cardiol. 2006;22(10):863–868.
   PubMed Web of Science ®Google Scholar
• JG R, Farnier M, Krempf M, et al. ODYSSEY LONG TERM Investigators. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015;372(16):1489–1499.
   PubMed Web of Science ®Google Scholar
• MS S, RP G, SD W, et al. Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015;372(16):1500–1509.
   PubMed Web of Science ®Google Scholar
• GK H, Mh D, Jj K, et al. Diagnosis and treatment of familial hypercholesterolaemia. Eur Heart J. 2013;34(13):962–971.
   PubMed Web of Science ®Google Scholar
• VE B, AC G. Familial hypercholesterolemia. Cardiol Clin. 2015;33(2):169–179.
   PubMed Web of Science ®Google Scholar
• Kindt I, Mata P, Jw K. The role of registries and genetic databases in familial hypercholesterolemia. Curr Opin Lipidol. 2017;28:152–160.
   PubMed Web of Science ®Google Scholar
• TP L, TH F, TE M, et al. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening. Community Genet. 2008;11:26–35.
   PubMedGoogle Scholar
• WA N, Knowles J, Wilemon K. Underutilization of cascade screening for familial hypercholesterolemia. Clin Lipidol. 2014;9:291–293.
   Google Scholar